Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.57 -0.19 (-0.52%)
As of: Sep 9, 2026 · 2:26 PM EDT

Teva Pharmaceutical Industries (TEVA) EBT Margin (QoQ) (2009 - 2026)

Analysis

Teva Pharmaceutical Industries (TEVA) EBT Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,196.00
Mar 31, 2026 928.00
Dec 31, 2025 -1,272.00
Sep 30, 2025 956.00
Jun 30, 2025 -269.00
Mar 31, 2025 1,607.00
Dec 31, 2024 -104.00
Sep 30, 2024 -157.00
Jun 30, 2024 -1,814.00
Mar 31, 2024 85.00
Dec 31, 2023 971.00
Sep 30, 2023 2,546.00
Jun 30, 2023 -1,637.00
Mar 31, 2023 2,308.00
Dec 31, 2022 -3,527.00
Sep 30, 2022 3,587.00
Jun 30, 2022 -459.00
Mar 31, 2022 -2,225.00
Dec 31, 2021 -1,410.00
Sep 30, 2021 195.00